Will Kaiser, PhD, is a Senior Principal Scientist in the Protein Characterisation Team at Lonza Biologics, Slough (CDMO), where he has worked for the last 12 years. Here, Will supports biochemical/biophysical characterisation and comparability studies for early, late phase and commercial protein products. Prior to joining Lonza, Will worked at the University of Reading in platelet research, involving proteomics, peptide hormones, cell signalling and molecular biology.
In antibody-drug conjugates (ADCs), the drug load, that is how many drugs are attached to an antibody, and the drug’s sites of attachment, are important quality characteristics that can be assessed by mass spectrometry.
Join this session to learn for two separate presentations that cover:
Senior Principal Scientist, Protein Characterisation Team
Lonza Biologics
Principal Scientist
Dragonfly Therapeutics
© Copyright 2024 Russell Publishing Limited.
All Rights Reserved.
Registered address: Court Lodge, Hogtrough Hill, Brasted, Kent, TN16 1NU, United Kingdom
Company registration number: 2709148
+44 (0)1959 563 311
[email protected]
Access the latest news, articles, interviews and insights at European Pharmaceutical Review
